一种安全,有效和可适应的活体减弱的SARS-CoV-2疫苗,用于减少疾病和传播,使用一站式基因组修改
Jacob Schön1, G Tuba Barut2,3, Bettina Salome Trüeb2,3
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Nature microbiology
|July 12, 2024
概括
针对SARS-CoV-2的新活体减弱疫苗 (LAVs) 提供了对变种的广泛保护. 这些基因组修改疫苗,如OTS-228,通过鼻内注射提供消毒免疫力,并优化了安全性.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 基因工程是一种基因工程.
背景情况:
- 经批准的COVID-19疫苗是有效的,但需要对新兴变种和传播进行增强.
- 需要疫苗来诱导更广泛的免疫力,而不仅仅是预防严重疾病.
研究的目的:
- 通过基因组修饰开发针对SARS-CoV-2的新型活衰减疫苗 (LAV).
- 为了增强宿主免疫反应,并优化SARS-CoV-2疫苗的安全性.
主要方法:
- 复制SARS-CoV-2的基因组编码,包括"一站式" (OTS) 编码子,禁用NSP1的翻译抑制,并删除特定的ORF (6,7ab,8).
- 修改尖多基分裂部位以提高安全性.
- 开发可调节衰减的内鼻注射,基因稳定的LAVs (OTS-206,OTS-228).
主要成果:
- 在临床前模型中,OTS-228表现出最佳的安全性,没有观察到副作用或传播.
- 一次剂量OTS-228诱导了对野生型SARS-CoV-2的灭菌免疫力.
- 对Omicron变种 (BA.2,BA.5,XBB.1.5) 实现了广泛的保护,病毒传播减少.
结论:
- 基因组修改的SARS-CoV-2 LAVs,特别是OTS-228,代表了一个有前途的疫苗策略.
- 鼻内注射和对变种的广泛保护突出了这种LAV方法的潜力.
- 开发的LAV平台可能适应其他新出现的病毒威胁.
相关概念视频
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...


